Impax Asset Management Group plc boosted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,014 shares of the specialty pharmaceutical company’s stock after acquiring an additional 300 shares during […]
Impax Asset Management Group plc increased its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,014 shares of the specialty pharmaceutical company’s stock after purchasing an additional 300 […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totalling 2,610,000 shares, a decline of 19.9% from the September 30th total of 3,260,000 shares. Based on an average daily volume of 555,700 shares, the days-to-cover ratio […]
Meritage Portfolio Management trimmed its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 8.5% during the 2nd quarter, Holdings Channel reports. The fund owned 77,981 shares of the specialty pharmaceutical company’s stock after selling 7,289 shares during the quarter. Meritage Portfolio Management’s holdings in Jazz Pharmaceuticals were worth $9,667,000 as of […]
Vontobel Holding Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,566 shares of the specialty pharmaceutical company’s stock after selling 305 shares during the period. Vontobel Holding […]